A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Synthesis and biological evaluation of novel I-123-labeled 4-(4-iodophenyl)butanoyl-L-prolyl-(2S)-pyrrolidines for imaging prolyl oligopeptidase in vivo
Tekijät: Kallinen A, Todorov B, Kallionpaa R, Back S, Sarparanta M, Raki M, Garcia-Horsman JA, Bergstrom KA, Wallen EAA, Mannisto PT, Airaksinen AJ
Kustantaja: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
Julkaisuvuosi: 2014
Journal: European Journal of Medicinal Chemistry
Tietokannassa oleva lehden nimi: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Lehden akronyymi: EUR J MED CHEM
Vuosikerta: 79
Aloitussivu: 436
Lopetussivu: 445
Sivujen määrä: 10
ISSN: 0223-5234
DOI: https://doi.org/10.1016/j.ejmech.2014.04.014
Tiivistelmä
Prolyl oligopeptidase (POP) may be associated with neuromodulation and development of neurodegenerative diseases and it was recently shown to participate in the inflammatory cascade along with matrix metalloproteinases. Radiotracers, which can be used for non-invasive imaging, are needed for investigating the role of POP in normal physiology and in pathophysiological conditions in vivo. We synthesized two novel POP-specific I-123-radiolabeled 4-phenylbutanoyl-L-prolyl-pyrrolidines of which 4(4-[I-123]iodophenyl)butanoyl-r-proly1-2(S)-cyanopyrrolidine ([I-123]2f, K-i = 4.2 nM) was selected. The selected compound has an electrophilic cyano group that is known to increase the dissociation time of POP inhibitors. [I-123]2f was synthesized in high radiochemical yield and purity (87 4%, >99%, respectively) and with a specific activity of 456 98 GBq/mu mol. [1231]2f was evaluated in healthy mice (C57BI/6JRccHsd) by ex vivo biodistribution studies and SPECT imaging. Pretreatment with the known inhibitor 4-phenylbutanoyl-L-prolyl-(2S)-cyanopyrrolidine (KYP-2047, 2d, K-i = 0.023 nM) showed that binding of [I-123]2f was POP specific. In addition, [1231]2f was evaluated in models of neuroinflammation and acute localized inflammation. A minor increase in binding of [I-123]2f was observed in the inflamed region in the acute localized inflammation model. Similar increase in binding was not observed in the neuroinflammation model. (c) 2014 Elsevier Masson SAS. All rights reserved.
Prolyl oligopeptidase (POP) may be associated with neuromodulation and development of neurodegenerative diseases and it was recently shown to participate in the inflammatory cascade along with matrix metalloproteinases. Radiotracers, which can be used for non-invasive imaging, are needed for investigating the role of POP in normal physiology and in pathophysiological conditions in vivo. We synthesized two novel POP-specific I-123-radiolabeled 4-phenylbutanoyl-L-prolyl-pyrrolidines of which 4(4-[I-123]iodophenyl)butanoyl-r-proly1-2(S)-cyanopyrrolidine ([I-123]2f, K-i = 4.2 nM) was selected. The selected compound has an electrophilic cyano group that is known to increase the dissociation time of POP inhibitors. [I-123]2f was synthesized in high radiochemical yield and purity (87 4%, >99%, respectively) and with a specific activity of 456 98 GBq/mu mol. [1231]2f was evaluated in healthy mice (C57BI/6JRccHsd) by ex vivo biodistribution studies and SPECT imaging. Pretreatment with the known inhibitor 4-phenylbutanoyl-L-prolyl-(2S)-cyanopyrrolidine (KYP-2047, 2d, K-i = 0.023 nM) showed that binding of [I-123]2f was POP specific. In addition, [1231]2f was evaluated in models of neuroinflammation and acute localized inflammation. A minor increase in binding of [I-123]2f was observed in the inflamed region in the acute localized inflammation model. Similar increase in binding was not observed in the neuroinflammation model. (c) 2014 Elsevier Masson SAS. All rights reserved.
Turun yliopiston Tutkimustietojärjestelmän portaali